Bill: Let’s Study The Benefits Of Magic Mushrooms
A temporary Medicinal Psilocybin Working Group would be established to make recommendations to the Hawaii Legislature.
A bill that calls for the state to study psychedelic mushrooms has been scheduled for .
was introduced by Rep. Chris Lee, the Democrat who chairs House Judiciary and who was instrumental last year in decriminalizing small amounts of pot.
The bill , “The legislature finds that studies conducted by nationally and internationally recognized medical institutions indicate that psilocybin has shown efficacy, tolerability, and safety in the treatment of a variety of mental health conditions, including addiction, depression, anxiety disorders, and end-of-life psychological distress.”
According to the bill, the U.S. Food and Drug Administration has determined that preliminary clinical evidence indicates that psilocybin “may demonstrate substantial improvement over available therapies for treatment-resistant depression” and has granted a “breakthrough therapy” designation for a treatment that uses psilocybin as a therapy for treatment-resistant depression.
HB 2567 — which faces a high hurdle of passing three House committees in order to advance to the Senate — calls for the working group to report back to the Legislature on its findings by the 2022 session.
CNN that a single dose of psilocybin, a compound found in “magic mushrooms,” provides “long-term relief of anxiety and depression in cancer patients,” according to a new study.
“In fact, cancer patients who were given psilocybin reported reductions in anxiety, depression, hopelessness, demoralization, and death anxiety more than four years after receiving the dose in combination with psychotherapy.”
